Vimentin

Subscribe to Selected New Research on Vimentin

3879 relevant articles (41 outcomes, 350 trials/studies) found for this Bio-Agent

Description: An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.

Relationship Network

Bio-Agent Context: Research Results

Macromolecular Substances: 43

Polymers: 3620

Biopolymers: 142

Intermediate Filament Proteins: 225

Vimentin: 3879

vimentin (1-96)

Amino Acids, Peptides, and Proteins

Proteins: 56522

Cytoskeletal Proteins: 481

Intermediate Filament Proteins: 225

Vimentin: 3879

vimentin (1-96)

Experts

1.	Pekny, Milos: 3 articles (08/2008 - 05/2004)
2.	Wilhelmsson, Ulrika: 3 articles (08/2008 - 05/2004)
3.	Ma, Ding: 3 articles (01/2008 - 06/2007)
4.	Menet, V: 3 articles (01/2004 - 08/2001)
5.	Privat, A: 3 articles (01/2004 - 08/2001)
6.	Otellin, V A: 2 articles (10/2008 - 01/2007)
7.	Kirik, O V: 2 articles (10/2008 - 01/2007)
8.	Lentsman, M V: 2 articles (10/2008 - 01/2007)
9.	Takeda, Masumi: 2 articles (08/2008 - 06/2007)
10.	Lewis, Geoffrey P: 2 articles (08/2008 - 06/2007)

Related Diseases

1.	Neoplasms (Cancer) 01/01/1992 - "Since ENU is most effective in producing tumors when administered at the 16-17th day of fetal life, vimentin-positive radial glia is a candidate target of ENU" 01/01/2007 - "A more recent version including an epigenetic marker for the vimentin gene has further improved sensitivity for cancer, but performance relative to GFOBT or FIT is not clear" 06/01/1990 - "It indicated that vimentin antibody is effective for tumor differential diagnosis in surgical pathology." 09/01/2007 - "CONCLUSION: The above results, a specially localization, tumor size, mitotic index, CD117, CD34 and vimentin positivity, may be helpful for setting of a widespread criteria for diagnostic and differential diagnosis of GIST and their use in practice and therapy." 04/01/1993 - "Immunohistochemically, tumor cells had positive results only for vimentin" Get all the results and reference details, order at left...
2.	Carcinoma (Carcinomatosis) 03/01/2007 - "Ovarian clear-cell carcinoma showed weakly positive results in EMA staining and negative results in ER, PR, 34betaE12, and vimentin staining" 01/01/1990 - "Thus, vimentin expression may be helpful in identifying a substantial subset of ER-independent breast carcinomas with poor prognostic indicators." 08/01/1996 - "Vimentin expression in different types of breast carcinoma immunohistochemical study." 03/01/1994 - "Further studies into MAP and vimentin and their role in the prognosis of infiltrating ductal breast carcinomas appear to be important." 10/01/2008 - "CK5/6, CK14, vimentin and 34 beta E12, in increasing order of proportion, were detected in invasive carcinomas" Get all the results and reference details, order at left...
3.	Adenocarcinoma 03/15/1998 - "The interactions of tau with vimentin filaments, and its relationships with other filaments of the cytoskeletal network, were analyzed in SW-13 adenocarcinoma cells, through an integrated approach that included biochemical and immunological studies" 12/01/1996 - "This study was designed to clarify the significance of vimentin expression in solid type poorly differentiated adenocarcinomas of the stomach" 06/01/1992 - "This study also demonstrated consistent negative expression of vimentin in invasive cervical adenocarcinoma" 08/01/1986 - "Ultrastructural studies corroborate the perinuclear vimentin immunostaining pattern we observed in endometrial adenocarcinomas" 01/01/2006 - "Poor differentiated gastric adenocarcinoma with rhabdoid features vimentin-negative and colonized by candidas]" Get all the results and reference details, order at left...
4.	Mesothelioma 05/01/1985 - "Because tissue culture studies have suggested that mesothelial cells might produce large amounts of vimentin, I stained eight mesotheliomas (two fixed in alcohol) for vimentin using the Gown and Vogel monoclonal antibody 43 beta E8" 06/01/2001 - "Positive staining for HBME-1 and vimentin had the highest sensitivity (90.9% and 100%, respectively) and specificity (91.3% and 60%, respectively) for mesothelioma" 12/01/1998 - "The immunophenotype "vimentin-positive, ACE-negative, CA19.9-negative" yielded 100% sensitivity and 97% specificity for diagnosis of mesothelioma" 05/01/1998 - "Positive staining for vimentin had the highest sensitivity (87.5%) with 95.7% specificity for mesothelioma" 04/01/1995 - "Vimentin expression was noted in 18 of 19 SFTs and in seven of eight desmoplastic mesotheliomas" Get all the results and reference details, order at left...
5.	Sarcoma (Soft Tissue Sarcoma) 07/01/2007 - "We discuss the differential diagnosis versus other forms of sarcoma, examining the morphological appearance that is frequently very similar, the immunohistochemical expression of MIB-1, vimentin, S-100, CD-34, CD68, EMA, as well as conventional clinicopathological features that may help to distinguish FS from other sarcomas." 11/01/1989 - "Previous studies have shown that vimentin, an intermediate filament protein, is reduced in amount in cells acutely infected with Moloney mouse sarcoma virus (Mo-MuSV)" 05/01/2008 - "These findings, together with the coexpression of vimentin and alpha-smooth muscle actin, suggested that the sarcoma was derived from myofibroblasts" 05/01/2008 - "Today, this term is synonymous of pleomorphic undifferentiated sarcoma and has been an exclusion diagnosis (Vimentin [+]/ CD 68 [+]--occasionally--without ultrastructural differences), reserving the inflammatory subtype for which they have an inflammatory and histiocytic component" 03/01/2004 - "Immunohistochemically, Ewing's sarcomas are positive for vimentin and MIC-2 gene product (CD99)" Get all the results and reference details, order at left...
518 Diseases and 3879 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Keratins (Keratin)
2.	Antibodies
3.	S100 Proteins (S 100 Protein)
4.	Carcinoembryonic Antigen
5.	Desmin
6.	CA-15-3 Antigen (CA 15-3 Antigen)
7.	Glial Fibrillary Acidic Protein
8.	Phosphopyruvate Hydratase (Enolase)
9.	Antigens
10.	Monoclonal Antibodies
748 Drugs and Important Bio-Agents and 3068 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Transplantation (Transplant Recipients)
3.	Adjuvant Chemotherapy
4.	Pancreatectomy
5.	Heterologous Transplantation (Xenotransplantation)
28 Therapies and Procedures and 61 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>